Lead Center:Moss Traumatic Brain Injury Model System
Principal Investigator Name:John Whyte, MD, Ph.D. & Thomas Watanabe, M.D.
Principal Investigator Email:email@example.com
This project is a placebo-controlled pilot study of the effects of dextroamphetamine (DEX) on attention, engagement in therapy, cognitive and motor speed, and other outcomes in subacute TBI. We will also examine the possibility that DEX accelerates the pace of functional recovery in the subacute phase.